The preventive role of transurethral antibiotic delivery in a rat model

References

• Bootsma AM Laguna Pes MP Geerlings SE Goossens A Antibiotic prophylaxis in urologic procedures: a systematic review Eur Urol 2008 54 6 1270 1286 18423974
   PubMed Web of Science ®Google Scholar
• Grabe M Controversies in antibiotic prophylaxis in urology Int J Antimicrob Agents 2004 23 Suppl 1 S17 23 15037324
   PubMed Web of Science ®Google Scholar
• Almallah YZ Rennie CD Stone J Lancashire MJ Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation Urology 2000 56 1 37 39 10869618
   PubMed Web of Science ®Google Scholar
• Clark KR Higgs MJ Urinary infection following out-patient flexible cystoscopy Br J Urol 1990 66 5 503 505 2249120
   PubMedGoogle Scholar
• Naber KG Hofstetter AG Brühl P for Working group ‘Urinary Tract Infections’ of the Paul Erlich Societ for Chemotherapy; for Working group ‘Urological Infections’ of the German Society for Urology Guidelines for the perioperative prophylaxis in urological interventions of the urinary and male genital tract Int J Antimicrob Agents 2001 17 4 321 326 11295416
   PubMed Web of Science ®Google Scholar
• Patel SS Balfour JA Bryson HM Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections Drugs 1997 53 4 637 656 9098664
   PubMed Web of Science ®Google Scholar
• Dubini F Riviera L Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol Chemioterapia 1988 7 1 24 28 3259910
   PubMedGoogle Scholar
• Arda M Temel Mikrobiyoloji 2nd ed Ankara, Turkey Medisan Press 2000
   Google Scholar
• Babacan O Detection of virulence factors of Escherichia coli strains isolated from urogenital system infections in dogs and cats Doctoral Thesis Ankara University Health Science Institute Ankara, Turkey 2011
   Google Scholar
• Yamamoto S Terai A Yuri K Kurazono H Takeda Y Yoshida O Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction FEMS Immunol Med Microbiol 1995 12 2 85 90 8589667
   PubMedGoogle Scholar
• Johnson JR Stell AL Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise J Infect Dis 2000 181 1 261 272 10608775
   PubMed Web of Science ®Google Scholar
• Bauer RJ Zhang L Foxman B Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN (E. coli) J Infect Dis 2002 185 10 1521 1524 11992291
   PubMed Web of Science ®Google Scholar
• Hopkins WJ Gendron-Fitzpatrick A Balish E Uehling DT Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains Infect Immun 1998 66 6 2798 2802 9596750
   PubMed Web of Science ®Google Scholar
• Nelson LK D’Amours GH Sproule-Willoughby KM Morck DW Ceri H Pseudomonas aeruginosa las and rhl quorum-sensing systems are important for infection and inflammation in a rat prostatitis model Microbiology 2009 155 Pt 8 2612 2619 19460822
   PubMed Web of Science ®Google Scholar
• Afşar I Gönül B Şener AG Türker M In-vitro susceptibility of clinical isolates of escherichia coli to fosfomycin trometamol and other antibiotics ANKEM Derg 2005 19 2 77 79
   Google Scholar
• Knottnerus BJ Nys S Ter Riet G Donker G Geerlings SE Stobberingh E Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother 2008 62 2 356 359 18424789
   PubMed Web of Science ®Google Scholar
• Bergan T Thorsteinsson SB Albini E Pharmacokinetic profile of fosfomycin trometamol Chemotherapy 1993 39 5 297 301 8370321
   PubMed Web of Science ®Google Scholar
• Ishizaka K Kobayashi S Machida T Yoshida K Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery J Infect Chemother 2007 13 5 324 331 17982722
   PubMedGoogle Scholar
• Shinagawa N Mizuno I Fukui T Prophylactic effect of fosfomycin on postoperative infection in gastroenterological surgery Jpn J Antibiot 2006 59 6 417 427 17334060
   PubMedGoogle Scholar
• Selvaggi FP Battaglia M Grossi FS Disabato G Cormio L Oral prophylaxis with fosfomycin trometamol in transurethral prostatectomy and urological maneuvers: literature review and personal experience Infection 1992 20 Suppl 4 S321 324 1294527
   PubMed Web of Science ®Google Scholar
• Baert L Billiet I Vandepitte J Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection Infection 1990 18 Suppl 2 S103 106 2286454
   PubMed Web of Science ®Google Scholar
• Periti P Novelli A Reali EF Lamanna S Fontana P Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial Eur Urol 1987 13 Suppl 1 S122 131
   Google Scholar
• di Silverio F Ferrone G Carati L Prophylactic chemotherapy with fosfomycin trometamol during transurethral surgery and urological manoeuvres. Results of a multicentre study Infection 1990 18 Suppl 2 S98 102 2286470
   PubMed Web of Science ®Google Scholar
• Leach JL Wright CG Edwards LB Meyerhoff WL Effect of topical fosfomycin on polymyxin B ototoxicity Arch Otolaryngol Head Neck Surg 1990 116 1 49 53 2153024
   PubMedGoogle Scholar